104 related articles for article (PubMed ID: 22568098)
21. Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors.
Zhu S; Schuerch C; Hunt J
Arch Pathol Lab Med; 2015 Jan; 139(1):55-66. PubMed ID: 25549144
[TBL] [Abstract][Full Text] [Related]
22. [Report of the National Oncology Research and Developement Consortium, 2003].
Tímár J
Magy Onkol; 2004; 48(1):75-9. PubMed ID: 15105900
[TBL] [Abstract][Full Text] [Related]
23. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models.
Futami K; Kumagai E; Makino H; Sato A; Takagi M; Shimamoto A; Furuichi Y
Cancer Sci; 2008 Jun; 99(6):1227-36. PubMed ID: 18422747
[TBL] [Abstract][Full Text] [Related]
24. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
Bădulescu F; Bădulescu A; Crişan A; Popescu FC
Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
[TBL] [Abstract][Full Text] [Related]
25. Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer.
Chen ZG
Curr Cancer Drug Targets; 2007 Nov; 7(7):613-22. PubMed ID: 18045066
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis.
Giwercman A; Andrews PW; Jørgensen N; Müller J; Graem N; Skakkebaek NE
Cancer; 1993 Aug; 72(4):1308-14. PubMed ID: 8339218
[TBL] [Abstract][Full Text] [Related]
27. [Detection of human papilloma virus DNA and expression of p53 protein in patients with head and neck cancer].
Takano I; Tamura S; Yamanaka N
Nihon Jibiinkoka Gakkai Kaiho; 1997 May; 100(5):524-33. PubMed ID: 9184031
[TBL] [Abstract][Full Text] [Related]
28. Polymorphous low-grade adenocarcinoma of the head and neck.
Verma V; Mendenhall WM; Werning JW
Am J Clin Oncol; 2014 Dec; 37(6):624-6. PubMed ID: 23428952
[TBL] [Abstract][Full Text] [Related]
29. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
Lim Y; Sun CX; Tran P; Punyadeera C
Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
Schwartz MK
Tumour Biol; 1987; 8(2-3):106-8. PubMed ID: 2452467
[No Abstract] [Full Text] [Related]
31. Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.
Fonseca FP; Sena Filho M; Altemani A; Speight PM; Vargas PA
J Oral Pathol Med; 2016 Feb; 45(2):101-10. PubMed ID: 25990369
[TBL] [Abstract][Full Text] [Related]
32. RECQL1 plays an important role in the development of tongue squamous cell carcinoma.
Tao J; Tao S; Han J; Zhou Z; Zhang X; Wang H; Chen R; Ji F; Zhu Y
Cell Physiol Biochem; 2014; 33(5):1579-90. PubMed ID: 24854846
[TBL] [Abstract][Full Text] [Related]
33. BSND is a Novel Immunohistochemical Marker for Oncocytic Salivary Gland Tumors.
Shinmura K; Kato H; Kawanishi Y; Kamo T; Inoue Y; Yoshimura K; Sugiyama K; Misawa K; Hosokawa S; Mineta H; Sugimura H
Pathol Oncol Res; 2018 Apr; 24(2):439-444. PubMed ID: 28470573
[TBL] [Abstract][Full Text] [Related]
34. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
35. Glycoprotein tumour markers in head and neck neoplasms--a consecutive study on CA-50, CA 19-9, and CEA.
Gustafsson H; Franzén L; Grankvist K; Anniko M; Henriksson R
J Cancer Res Clin Oncol; 1988; 114(4):394-8. PubMed ID: 3165978
[TBL] [Abstract][Full Text] [Related]
36. Mucoepidermoid carcinoma of the head and neck in children.
Dombrowski ND; Wolter NE; Irace AL; Cunningham MJ; Mack JW; Marcus KJ; Vargas SO; Perez-Atayde AR; Robson CD; Rahbar R
Int J Pediatr Otorhinolaryngol; 2019 May; 120():93-99. PubMed ID: 30772619
[TBL] [Abstract][Full Text] [Related]
37. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
38. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
39. Exploring biomarkers in head and neck cancer.
Langer CJ
Cancer; 2012 Aug; 118(16):3882-92. PubMed ID: 22281752
[TBL] [Abstract][Full Text] [Related]
40. Emerging biomarkers in head and neck cancer in the era of genomics.
Kang H; Kiess A; Chung CH
Nat Rev Clin Oncol; 2015 Jan; 12(1):11-26. PubMed ID: 25403939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
